Stay updated with breaking news from Balance Analyzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics Euronext Growth Paris ISIN: FR0014005I80 Ticker: ALSMA), a French player specializing in transforming vertebral
Software, Machines and Adaptative Implants in Orthopaedics recieved FDA 510(k) clearance for its custom surgery planning software developed with NuVasive.
2022 sales up +15% to €2.4 million driven by international business Significant improvement in the margin on cost of sales to 63% from 55% in 2021 thanks to an increased presence in high value-added
Strong growth of +60% in international sales Video interview: Philippe Roussouly, Chairman and CEO of SMAIO, discusses the Company's 2022 achievements and 2023 prospects Regulatory News:
First-half 2022 sales up +28% to €1.3 million Improvement in the sales margin thanks to better implant procurement conditions Exceptional income of +€7.4 million resulting from the dropping